HYEX — Healthy Extracts Cashflow Statement
0.000.00%
- $10.18m
- $11.00m
- $3.11m
- 51
- 20
- 42
- 30
Annual cashflow statement for Healthy Extracts, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | C2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K/A | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -2.58 | -1.99 | -0.983 | -2.47 | -0.841 |
Depreciation | |||||
Non-Cash Items | 0.527 | 0.694 | 0.359 | 1.59 | 0.812 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 0.138 | 0.387 | 0.233 | 0.463 | 0.31 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -1.9 | -0.901 | -0.391 | -0.416 | 0.282 |
Capital Expenditures | -0.116 | -0.096 | -0.008 | 0 | — |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 0 | 0 | 0.003 | — | 0 |
Sale of Business | |||||
Sale of Fixed Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -0.116 | -0.096 | -0.005 | 0 | 0 |
Financing Cash Flow Items | — | — | 0 | 0.069 | 0 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 1.94 | 1.16 | 0.24 | 0.37 | -0.189 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -0.074 | 0.163 | -0.156 | -0.046 | 0.093 |